Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Feb 15;97(4):1117–1121. doi: 10.1172/JCI118505

In vivo neutralization of eosinophil-derived major basic protein inhibits antigen-induced bronchial hyperreactivity in sensitized guinea pigs.

J Lefort 1, M A Nahori 1, C Ruffie 1, B B Vargaftig 1, M Pretolani 1
PMCID: PMC507160  PMID: 8613536

Abstract

This study examines the effect of purified rabbit antiguinea pig eosinophil-derived major basic protein (MBP) Ig on antigen-induced bronchial hyperreactivity to inhaled acetylcholine in aerosol-sensitized guinea pigs. Ovalbumin inhalation by sensitized guinea pigs induced a rise in the numbers of eosinophils and in the levels of MBP in the bronchoalveolar lavage fluid, which peaked at 24 h and resolved at 72 h. Antigen-challenged animals exhibited bronchial hyperreactivity to inhale acetylcholine at 72 h, but not at 6 or 24 h. The intranasal administration of 200 microliter of purified rabbit anti-guinea pig MBP Ig, at 2.5 mg/ml, but not of the control preimmune rabbit Ig, 1 h before and 5 h after ovalbumin inhalation suppressed bronchial hyperreactivity to acetylcholine at 72 h without affecting the number of eosinophils accumulating in the bronchoalveolar lavage fluid. These findings indicate that antigen challenge in sensitized guinea pigs is followed by early eosinophil infiltration and activation within the airways and by late bronchial hyperreactivity. Neutralization of endogenously secreted MBP by a specific antiserum prevented antigen-induced bronchial hyperreactivity, suggesting that eosinophil degranulation plays an important role in the alterations of bronchopulmonary function in the guinea pig.

Full Text

The Full Text of this article is available as a PDF (167.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barker R. L., Gundel R. H., Gleich G. J., Checkel J. L., Loegering D. A., Pease L. R., Hamann K. J. Acidic polyamino acids inhibit human eosinophil granule major basic protein toxicity. Evidence of a functional role for ProMBP. J Clin Invest. 1991 Sep;88(3):798–805. doi: 10.1172/JCI115379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bousquet J., Chanez P., Lacoste J. Y., Barnéon G., Ghavanian N., Enander I., Venge P., Ahlstedt S., Simony-Lafontaine J., Godard P. Eosinophilic inflammation in asthma. N Engl J Med. 1990 Oct 11;323(15):1033–1039. doi: 10.1056/NEJM199010113231505. [DOI] [PubMed] [Google Scholar]
  3. Brofman J. D., White S. R., Blake J. S., Munoz N. M., Gleich G. J., Leff A. R. Epithelial augmentation of trachealis contraction caused by major basic protein of eosinophils. J Appl Physiol (1985) 1989 Apr;66(4):1867–1873. doi: 10.1152/jappl.1989.66.4.1867. [DOI] [PubMed] [Google Scholar]
  4. Coyle A. J., Ackerman S. J., Burch R., Proud D., Irvin C. G. Human eosinophil-granule major basic protein and synthetic polycations induce airway hyperresponsiveness in vivo dependent on bradykinin generation. J Clin Invest. 1995 Apr;95(4):1735–1740. doi: 10.1172/JCI117850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Coyle A. J., Ackerman S. J., Irvin C. G. Cationic proteins induce airway hyperresponsiveness dependent on charge interactions. Am Rev Respir Dis. 1993 Apr;147(4):896–900. doi: 10.1164/ajrccm/147.4.896. [DOI] [PubMed] [Google Scholar]
  6. Coyle A. J., Perretti F., Manzini S., Irvin C. G. Cationic protein-induced sensory nerve activation: role of substance P in airway hyperresponsiveness and plasma protein extravasation. J Clin Invest. 1994 Dec;94(6):2301–2306. doi: 10.1172/JCI117594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Egesten A., Alumets J., von Mecklenburg C., Palmegren M., Olsson I. Localization of eosinophil cationic protein, major basic protein, and eosinophil peroxidase in human eosinophils by immunoelectron microscopic technique. J Histochem Cytochem. 1986 Nov;34(11):1399–1403. doi: 10.1177/34.11.3772075. [DOI] [PubMed] [Google Scholar]
  8. Filley W. V., Holley K. E., Kephart G. M., Gleich G. J. Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma. Lancet. 1982 Jul 3;2(8288):11–16. doi: 10.1016/s0140-6736(82)91152-7. [DOI] [PubMed] [Google Scholar]
  9. Frigas E., Loegering D. A., Gleich G. J. Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium. Lab Invest. 1980 Jan;42(1):35–43. [PubMed] [Google Scholar]
  10. Fryer A. D., Jacoby D. B. Function of pulmonary M2 muscarinic receptors in antigen-challenged guinea pigs is restored by heparin and poly-L-glutamate. J Clin Invest. 1992 Dec;90(6):2292–2298. doi: 10.1172/JCI116116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fryer A. D., Wills-Karp M. Dysfunction of M2-muscarinic receptors in pulmonary parasympathetic nerves after antigen challenge. J Appl Physiol (1985) 1991 Dec;71(6):2255–2261. doi: 10.1152/jappl.1991.71.6.2255. [DOI] [PubMed] [Google Scholar]
  12. Gleich G. J., Frigas E., Loegering D. A., Wassom D. L., Steinmuller D. Cytotoxic properties of the eosinophil major basic protein. J Immunol. 1979 Dec;123(6):2925–2927. [PubMed] [Google Scholar]
  13. Gleich G. J., Loegering D. A., Maldonado J. E. Identification of a major basic protein in guinea pig eosinophil granules. J Exp Med. 1973 Jun 1;137(6):1459–1471. doi: 10.1084/jem.137.6.1459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gleich G. J. The eosinophil and bronchial asthma: current understanding. J Allergy Clin Immunol. 1990 Feb;85(2):422–436. doi: 10.1016/0091-6749(90)90151-s. [DOI] [PubMed] [Google Scholar]
  15. Griffin E., Håkansson L., Formgren H., Jörgensen K., Peterson C., Venge P. Blood eosinophil number and activity in relation to lung function in patients with asthma and with eosinophilia. J Allergy Clin Immunol. 1991 Feb;87(2):548–557. doi: 10.1016/0091-6749(91)90014-f. [DOI] [PubMed] [Google Scholar]
  16. Gundel R. H., Letts L. G., Gleich G. J. Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. J Clin Invest. 1991 Apr;87(4):1470–1473. doi: 10.1172/JCI115155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Holgate S. T. The 1992 Cournand Lecture. Asthma: past, present and future. Eur Respir J. 1993 Nov;6(10):1507–1520. [PubMed] [Google Scholar]
  18. Hunt T. C., Summers J. A., Campos M. G., Rimmer S. J., Sturton G., Palfai S., Church M. K. Monoclonal antibodies specific for guinea pig eosinophil major basic protein: their use in an ELISA, immunocytochemistry and flow cytometry. Clin Exp Allergy. 1993 May;23(5):425–434. doi: 10.1111/j.1365-2222.1993.tb00349.x. [DOI] [PubMed] [Google Scholar]
  19. Laitinen L. A., Heino M., Laitinen A., Kava T., Haahtela T. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis. 1985 Apr;131(4):599–606. doi: 10.1164/arrd.1985.131.4.599. [DOI] [PubMed] [Google Scholar]
  20. Metzger W. J., Zavala D., Richerson H. B., Moseley P., Iwamota P., Monick M., Sjoerdsma K., Hunninghake G. W. Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs. Description of the model and local airway inflammation. Am Rev Respir Dis. 1987 Feb;135(2):433–440. doi: 10.1164/arrd.1987.135.2.433. [DOI] [PubMed] [Google Scholar]
  21. Motojima S., Frigas E., Loegering D. A., Gleich G. J. Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. Am Rev Respir Dis. 1989 Mar;139(3):801–805. doi: 10.1164/ajrccm/139.3.801. [DOI] [PubMed] [Google Scholar]
  22. O'Donnell M. C., Ackerman S. J., Gleich G. J., Thomas L. L. Activation of basophil and mast cell histamine release by eosinophil granule major basic protein. J Exp Med. 1983 Jun 1;157(6):1981–1991. doi: 10.1084/jem.157.6.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Pretolani M., Ruffié C., Joseph D., Campos M. G., Church M. K., Lefort J., Vargaftig B. B. Role of eosinophil activation in the bronchial reactivity of allergic guinea pigs. Am J Respir Crit Care Med. 1994 May;149(5):1167–1174. doi: 10.1164/ajrccm.149.5.8173756. [DOI] [PubMed] [Google Scholar]
  24. Pretolani M., Ruffié C., Lapa e Silva J. R., Joseph D., Lobb R. R., Vargaftig B. B. Antibody to very late activation antigen 4 prevents antigen-induced bronchial hyperreactivity and cellular infiltration in the guinea pig airways. J Exp Med. 1994 Sep 1;180(3):795–805. doi: 10.1084/jem.180.3.795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Pretolani M., Vargaftig B. B. From lung hypersensitivity to bronchial hyperreactivity. What can we learn from studies on animal models? Biochem Pharmacol. 1993 Feb 24;45(4):791–800. doi: 10.1016/0006-2952(93)90161-o. [DOI] [PubMed] [Google Scholar]
  26. Sarmiento E. U., Espiritu B. R., Gleich G. J., Thomas L. L. IL-3, IL-5, and granulocyte-macrophage colony-stimulating factor potentiate basophil mediator release stimulated by eosinophil granule major basic protein. J Immunol. 1995 Aug 15;155(4):2211–2221. [PubMed] [Google Scholar]
  27. Sasaki M., Herd C. M., Page C. P. Effect of heparin and a low-molecular weight heparinoid on PAF-induced airway responses in neonatally immunized rabbits. Br J Pharmacol. 1993 Sep;110(1):107–112. doi: 10.1111/j.1476-5381.1993.tb13778.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Uchida D. A., Ackerman S. J., Coyle A. J., Larsen G. L., Weller P. F., Freed J., Irvin C. G. The effect of human eosinophil granule major basic protein on airway responsiveness in the rat in vivo. A comparison with polycations. Am Rev Respir Dis. 1993 Apr;147(4):982–988. doi: 10.1164/ajrccm/147.4.982. [DOI] [PubMed] [Google Scholar]
  29. Vanhoutte P. M. Epithelium-derived relaxing factor(s) and bronchial reactivity. J Allergy Clin Immunol. 1989 May;83(5):855–861. doi: 10.1016/0091-6749(89)90095-x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES